Drug Shortage Report for APO-VALSARTAN/HCTZ

Last updated on 2019-03-21 History
Report ID 269
Drug Identification Number 02382555
Brand name APO-VALSARTAN/HCTZ
Common or Proper name VALSARTAN/HCTZ
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) HYDROCHLOROTHIAZIDE VALSARTAN
Strength(s) 12.5MG 160MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500 BTL
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-01-04
Estimated end date
Actual end date 2018-12-28
Shortage status Resolved
Updated date 2019-03-21
Company comments Product Discontinued
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-03-21 French Compare
v3 2019-03-21 English Compare
v2 2017-03-10 French Compare
v1 2017-03-10 English Compare

Showing 1 to 4 of 4